Atlas Trials

Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy

Clinical trial NCT02324998 · COMPLETED

Trial details

NCT number
NCT02324998
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2016-12-01
Primary completion
2019-05-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.